Clinical Trials Browser

Interventional × ACTH Syndrome, Ectopic × 90 days × Clear all

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary ACTH Hypersecretion

NCT07296484 2026-05-12

CAPTAIN-T2D

Phase 2 Recruiting

1,500 enrolled

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

NCT02756754 2026-05-04

ADERADHTA

Phase NA Completed

31 enrolled

ACTH Syndrome, Ectopic, Hyperaldosteronism

NCT03604198 2026-04-21

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

125 enrolled

Endocrine

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT07361874 2026-03-27

IMPACT-MACS

Phase NA Recruiting

75 enrolled

Adrenal incidentaloma, ACTH Syndrome, Ectopic, Cushing Syndrome, Insulin Resistance, Weight Loss

Clinical Trials

A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome

CAPTAIN-T2D

ADERADHTA

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

IMPACT-MACS